Total Payments
$154,063
2024 Payments
$40,532
Companies
14
Transactions
42
Medicare Patients
6,957
Medicare Billing
$3.3M
Payment Breakdown by Category
Consulting$152,000 (98.7%)
Food & Beverage$1,938 (1.3%)
Other$125.00 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $152,000 | 4 | 98.7% |
| Food and Beverage | $1,938 | 37 | 1.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $125.00 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Digital Diagnostics Inc. | $152,000 | 4 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $362.18 | 8 | $0 (2024) |
| Regeneron Pharmaceuticals, Inc. | $272.33 | 2 | $0 (2024) |
| Genentech USA, Inc. | $260.77 | 7 | $0 (2024) |
| Apellis Pharmaceuticals, Inc. | $229.24 | 6 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $186.49 | 3 | $0 (2021) |
| NotalVision | $125.00 | 1 | $0 (2018) |
| Mallinckrodt Enterprises LLC | $119.31 | 1 | $0 (2019) |
| Johnson & Johnson Surgical Vision, Inc. | $109.18 | 1 | $0 (2018) |
| AbbVie, Inc. | $105.78 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $40,532 | 17 | Digital Diagnostics Inc. ($40,000) |
| 2023 | $44,333 | 11 | Digital Diagnostics Inc. ($44,000) |
| 2022 | $48,094 | 2 | Digital Diagnostics Inc. ($48,000) |
| 2021 | $20,018 | 2 | Digital Diagnostics Inc. ($20,000) |
| 2019 | $509.36 | 5 | Novartis Pharmaceuticals Corporation ($168.21) |
| 2018 | $234.18 | 2 | NotalVision ($125.00) |
| 2017 | $341.81 | 3 | Regeneron Pharmaceuticals, Inc. ($122.39) |
All Payment Transactions
42 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $24.52 | General |
| Category: Ophthalmology | ||||||
| 11/18/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $23.14 | General |
| Category: Immunology and Ophthalmology | ||||||
| 11/12/2024 | Regeneron Pharmaceuticals, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $149.94 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/21/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $32.52 | General |
| Category: IMMUNOLOGY | ||||||
| 08/20/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $31.34 | General |
| Category: Ophthalmology | ||||||
| 08/15/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $22.83 | General |
| Category: Immunology and Ophthalmology | ||||||
| 08/06/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $30.88 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/23/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/15/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $34.42 | General |
| Category: Ophthalmology | ||||||
| 06/25/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $31.42 | General |
| Category: Ophthalmology | ||||||
| 06/06/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $29.98 | General |
| Category: Ophthalmology | ||||||
| 05/28/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $24.78 | General |
| Category: Immunology and Ophthalmology | ||||||
| 05/13/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: OPHTHALMOLOGY | ||||||
| 04/11/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: Immunology and Ophthalmology | ||||||
| 01/31/2024 | Digital Diagnostics Inc. | LumineticsCore (Device) | Consulting Fee | Cash or cash equivalent | $40,000.00 | General |
| Category: Diagnostic Device | ||||||
| 01/24/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $27.97 | General |
| Category: IMMUNOLOGY | ||||||
| 01/08/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: Ophthalmology | ||||||
| 12/19/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/12/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $22.19 | General |
| Category: Immunology and Ophthalmology | ||||||
| 11/15/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $26.02 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $23.80 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/19/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/11/2023 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | Cash or cash equivalent | $32.08 | General |
| Category: Ophthalmology | ||||||
| 08/30/2023 | Biogen, Inc. | — | Food and Beverage | In-kind items and services | $15.82 | General |
| 08/03/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $23.70 | General |
| Category: Immunology and Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 3,138 | 12,409 | $5.6M | $1.8M |
| 2022 | 11 | 1,347 | 3,743 | $1.6M | $552,957 |
| 2021 | 10 | 1,165 | 3,295 | $1.4M | $478,370 |
| 2020 | 12 | 1,307 | 3,515 | $1.5M | $519,455 |
Total Patients
6,957
Total Services
22,962
Medicare Billing
$3.3M
Procedure Codes
56
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 282 | 1,682 | $3.4M | $1.2M | 34.3% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 28 | 5,460 | $458,640 | $157,764 | 34.4% |
| 67028 | Injection of drug into eye | Office | 2023 | 419 | 1,100 | $591,060 | $104,972 | 17.8% |
| Q5128 | Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | Office | 2023 | 38 | 317 | $317,000 | $68,422 | 21.6% |
| 92134 | Imaging of retina | Office | 2023 | 714 | 1,510 | $186,293 | $44,917 | 24.1% |
| J3490 | Unclassified drugs | Office | 2023 | 13 | 25 | $118,670 | $42,518 | 35.8% |
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | Office | 2023 | 14 | 315 | $105,840 | $37,914 | 35.8% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 225 | 239 | $64,346 | $25,691 | 39.9% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 214 | 214 | $67,410 | $23,515 | 34.9% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 212 | 235 | $62,275 | $22,484 | 36.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 195 | 235 | $47,000 | $16,426 | 34.9% |
| 67108 | Repair of detached retina with drainage and removal of eye fluid between lens and retina | Facility | 2023 | 13 | 14 | $33,670 | $13,244 | 39.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 108 | 108 | $37,766 | $12,995 | 34.4% |
| 67042 | Removal of membrane of retina with removal of internal limiting membrane of retina | Facility | 2023 | 14 | 14 | $32,340 | $12,645 | 39.1% |
| 92250 | Photography of the retina | Office | 2023 | 270 | 425 | $40,375 | $12,146 | 30.1% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2023 | 100 | 213 | $31,950 | $12,075 | 37.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 95 | 100 | $27,000 | $9,807 | 36.3% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 94 | 102 | $18,790 | $3,982 | 21.2% |
| 67145 | Photocoagulation treatment to prevent detachment of retina | Office | 2023 | 12 | 12 | $9,000 | $2,410 | 26.8% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 31 | 39 | $5,850 | $1,420 | 24.3% |
| J7999 | Compounded drug, not otherwise classified | Office | 2023 | 15 | 17 | $10,200 | $999.60 | 9.8% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2023 | 13 | 13 | $937.00 | $215.70 | 23.0% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2023 | 19 | 20 | $1,020 | $74.10 | 7.3% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 51 | 540 | $1.1M | $388,532 | 36.0% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 301 | 843 | $151,740 | $53,191 | 35.1% |
About Dr. Aaron Roller, M.D
Dr. Aaron Roller, M.D is a Ophthalmology healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/14/2007. The National Provider Identifier (NPI) number assigned to this provider is 1700085248.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Aaron Roller, M.D has received a total of $154,063 in payments from pharmaceutical and medical device companies, with $40,532 received in 2024. These payments were reported across 42 transactions from 14 companies. The most common payment nature is "Consulting Fee" ($152,000).
As a Medicare-enrolled provider, Roller has provided services to 6,957 Medicare beneficiaries, totaling 22,962 services with total Medicare billing of $3.3M. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Other Specialties Ophthalmology, Retina Specialist
- Location Austin, TX
- Active Since 07/14/2007
- Last Updated 11/03/2022
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1700085248
Products in Payments
- IDx-DR (Device) $112,000
- LumineticsCore (Device) $40,000
- EYLEA HD (Biological) $276.64
- Vabysmo (Drug) $260.77
- EYLEA AFLIBERCEPT INJECTION (Biological) $236.03
- ACTHAR (Biological) $205.82
- Syfovre (Drug) $135.74
- ForeseeHome (Device) $125.00
- EYLEA (Biological) $121.84
- BEOVU (Drug) $112.98
- Humira (Biological) $105.78
- XR (Device) $100.00
- Izervay (Drug) $90.36
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Austin
Vikram Durairaj, Md, MD
Ophthalmology — Payments: $516,103
Ophthalmology $516,103
Dr. Sheila Barbarino, M.d, M.D
Ophthalmology — Payments: $236,894
Ophthalmology $236,894
Dr. Thomas Walters, Md, MD
Ophthalmology — Payments: $217,539
Ophthalmology $217,539
Chirag Jhaveri, M.d, M.D
Ophthalmology — Payments: $211,408
Ophthalmology $211,408
Dr. Steven Dell, M.d, M.D
Ophthalmology — Payments: $177,840
Ophthalmology $177,840
Robert Wong, Md, MD
Ophthalmology — Payments: $118,721
Ophthalmology $118,721